Shun Zhang

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 14, 2022
Anlotinib Benefits the αPDL1 Immunotherapy by Activating ROS/JNK/AP-1 Pathway to Upregulate PDL1 Expression in Colorectal Cancer.

Bixian Luo, Shun Zhang, Dan Tan

Pageof 1

Frequent Collaborators

1 joint publications

Bixian Luo

1 joint publications

Dan Tan

1 joint publications

Xinbo Yu

1 joint publications

Jianwei Lin